4.13 USD
↘ 0.03 (0.67%)PRE MARKET (AS OF 07:01 AM EDT)
CAMP4 Therapeutics Corporation Common Stock
CAMPNASDAQ • USD
Market: OPEN
Shares of CAMP4 Therapeutics Corporation Common Stock (CAMP) are trading at $4.13. The stock presents a mixed profile: our models indicate a Buy for technical indicators, while underlying fundamentals flash a Sell. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On the valuation front, CAMP trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Aug 4, 2026.
Open?$4.18
High?$4.18
Low?$4.13
Prev. Close?$4.16
Volume?201
Avg. Volume?289.9K
VWAP?$4.17
Rel. Volume?0.00x
Bid / Ask
Bid?$3.49 × 100
Ask?$4.92 × 100
Spread?$1.43
Midpoint?$4.21
Valuation & Ratios
Market Cap?216.0M
Shares Out?51.9M
Float?28.8M
Float %?55.5%
P/E Ratio?N/A
P/B Ratio?6.99
EPS?-$1.66
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Camp4 Therapeutics Corp is a clinical-stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics to upregulate gene expression and restore healthy protein levels to treat various genetic diseases. The company focuses on genetic diseases of the central nervous system and liver. Its pipeline products include CMP-CPS-001 and CMP-SYNGAP. The company operates as a single operating segment, R&D, which engages in the development of a new class of RNA-based therapeutics to treat a broad range of genetic diseases.
Themes
Employees
48
Market Cap
218.6M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2024-10-11
Address
ONE KENDALL SQUARE
CAMBRIDGE, MA 02139
Phone: 617-651-8867
CAMBRIDGE, MA 02139
Phone: 617-651-8867
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?12
Z-Score?0
Momentum?50
Short Sent.?38
Piotroski F-Score?2/9Weak
Altman Z-Score?-3.02Distress
Confidence?58%Low
Short InterestHigh
Short % of Float?5.00%Elevated
Short Interest?1.4M
Days to Cover?9.1
Free Float28.8M
Avg Daily Volume158.5K
Settlement Date2026-07-15
Financial Health
Current Ratio?6.10Strong
Quick Ratio?6.10Strong
Cash Ratio?5.97Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score58/100
P/E?N/A▾
P/B?6.99FAIR▾
Peers100
S&P27
P/S?54.91HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-2.3CHEAP▾
S&P97
EV/Sales?29.69HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-279.3%WEAK▾
S&P3
ROA?-81.8%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-26248000
Enterprise Value?$116.8M
Fundamentals ratios updated end of day